Hualan Biological Bacterin Inc. is engaged in the R&D, production and sales of vial vaccines, bacterial vaccines and etc.

Navigation
  • Hualan Biological vaccine Co., Ltd.

    Wechat attention
    consulting service

  • Hualan Biological vaccine Co., Ltd.

    Wechat attention
    consulting service

contact us

0373-3559991

fax:0373-3519991

Adverse reaction Telephone:0373-3552342

address:No. 1-A-1, Hualan Avenue, Xinxiang City, Henan Province

1

Products

Hualan is the birthplace of the first marketed Influenza A (H1N1) Vaccine, (Split Virion) in the globe, and the first company whose plasma products gained GMP certificate in China

  • [ Group A and C Meningococcal Polysaccharide Vaccine ]

    0.5mL/dose

     ...

  • [ Influenza Vaccine (Split Virion), Inactivated, Quadrivalent ]

    0.5mL//vial

    Please read this ins...

  • [ Influenza Vaccine (Split Virion), Inactivated, Quadrivalent ]

    0.5mL//syringe

    Please read this ins...

  • [ Group ACYW135 Meningococcal Polysaccharide Vaccine ]

    200μg/vial

    [Drug Name]Generic N...

  • [ Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) ]

    10μg /0.5mL/syringe

    [Drug Name]Generic N...

  • [ Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) ]

    10μg /0.5mL/vial

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.25mL/syringe

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.5mL/syringe

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.5mL/vial

    [Drug Name]Generic N...

learn more

ABOUT US

Hualan Biological vaccine Co., Ltd.
Mainstay of Influenza Prevention and Control in China

Hualan Biological Bacterin Inc., a holding subsidiary of the Hualan Biological Engineering Inc., is engaged in the R&D, production and sale of vaccines. In 2009, it only took 87 days to develop the world’s first H1N1 Vaccine, and undertook nearly 40 % of the national storage task. It is the first influenza vaccine manufacturer in China, and the fifth in the world that passes the Pre-Qualification of World Health Organization. H7N9 and Quadrivalent Influenza Vaccine developed and applied by Hualan firstly in China are listed as key development projects by Ministry of Science and Technology. At present, there are six kinds of vaccines on the market, including Influenza Vaccine (Split Virion), Inactivated (Adult), Group ACYW135 Meningococcal Polysaccharide Vaccine, Recombinant Hepatitis B Vaccine, Influenza Vaccine (Split Virion), Inactivated (Children), Influenza Vaccine (Split, Virion), Inactivated, Quadrivalent (Adult), Group A and Group C Meningococcal Polysaccharide Vaccine.

learn more

NEWS

  • 2021-10-20

    省領導蒞臨鄭洛新國家自主創新示范區華蘭生物進行調研

      2月9日上午,省委書記、省人大常委會主任謝伏瞻,省委副書記、省長陳潤兒帶領省...

    learn more
  • 2021-10-20

    全球疫苗市場現狀分析以及2011市場戰略趨勢

      【慧聰制藥工業網】成本控制、流感疫苗之間競爭的日益加劇、后期研發線新產品的缺...

    learn more
  • 2021-10-20

    全球***能夠用于3歲以上人群接種的甲型H1N1流感疫苗獲批獲得國家400萬的訂單

      9月4日,國家食品藥品監管局批準了華蘭生物疫苗有限公司甲型H1N1流感疫苗注...

    learn more
  • 2021-10-20

    華蘭生物向部分發展中國家捐贈流感疫苗

      2018年9月9日,在2018年世界流感大會于北京召開之際,華蘭生物在中國疾...

    learn more
  • 2021-10-20

    Hualan Bio's Influenza Vaccine Passed GMP Qualification of Ukraine

      March 15, 2017, Hualan Bio's influ...

    learn more
  • 2021-10-20

    華蘭生物流感病毒裂解疫苗出口烏克蘭

      近期華蘭生物疫苗有限公司與烏克蘭客戶簽訂了20萬人份流感疫苗的銷售協議,目前...

    learn more
  • 2021-10-20

    華蘭流腦疫苗接受WHO評估 受聯合國兒童基金會青睞

      4月5日至8日,受聯合國兒童基金會委托,世界衛生組織流行病控制疫苗緊急接種和...

    learn more
  • 2021-10-20

    河南省藥監局李廣勝局長一行蒞臨華蘭調研

      2011年4月20日上午河南省食品藥品監督管理局李廣勝局長一行在新鄉市劉森副...

    learn more
  • 2021-10-20

    河南省流感防控策略學術研討會***結束

      7月7日,由河南省預防醫學會主辦,新鄉市疾病預防中心承辦,華蘭生物疫苗有限公...

    learn more
  • 2021-10-20

    河南省科技廳副廳長馬世民、張代民及河南省審計廳副廳長趙國新一行蒞臨華蘭考察工作

      2010年4月15日,河南省審計廳副廳長趙國新、河南省科技廳副廳長馬世民、張...

    learn more
Copyright Hualan Biological vaccine Co., Ltd. ICP:
色偷偷色偷偷色偷偷在线视频,欧美换爱交换乱理伦片1000部,丰满岳乱妇三级高清,大乳喷奶水榨乳在线